Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine and NRT for Nicotine Treatment Seekers
NCT01907594Phase 2Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2013
- Primary completion
- May 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in nicotine dependence, sponsored by New York State Psychiatric Institute. Planned start Aug 2013; status: withdrawn.
02
Drugs
d-cycloserine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01907594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01907594.